The catalog, in full.

An 11-amino-acid peptide derived from erythropoietin, but without the red-blood-cell effects. Engineered to keep the tissue-protection signal while dropping the blood-thickening side of EPO.

The most-studied repair peptide in the catalog. Short for Body Protection Compound — it comes from a stable fragment of a protein found in gastric juice. Researchers reach for it when soft-tissue, tendon, or gut-lining work is in scope.

A copper-binding tripeptide that naturally circulates in your body and declines with age. Studied for its role in skin remodeling, hair density, and collagen support.

A short tripeptide fragment (Lys-Pro-Val) from the C-terminus of α-MSH, studied for its anti-inflammatory signaling in gut and skin research models.

A fragment of Thymosin Beta-4, a naturally occurring repair signal in the body. Investigated for soft-tissue recovery, cell migration, and the way tissue rebuilds itself after stress or injury.

BPC-157 and TB-500 in a single co-formulated vial. Two of the most-studied tissue-repair peptides supplied together for combined recovery research.

A small fragment of growth hormone, engineered to keep the fat-metabolism signal while dropping the broader growth effects. The C-terminal piece of hGH most tied to lipolysis.

Eli Lilly's triple agonist — a single peptide that works on three gut-hormone pathways (GLP-1, GIP, and glucagon) at once. Phase 2 trials showed up to ~24% body-weight reduction at 48 weeks at higher doses, with improvements in glucose control and liver fat.

An "exercise-mimetic" compound developed at Saint Louis University. Activates the metabolic gene programs your cells use during endurance training — fat-oxidation, mitochondrial biogenesis, oxidative metabolism.

A dual GIP/GLP-1 receptor agonist — one peptide that activates two incretin pathways at once. Widely studied for weight-management and glucose-control research, often as a comparator to GLP-1 monotherapy and to triple agonists like retatrutide.

The long-acting version of CJC-1295. A small modification (the Drug Affinity Complex) lets it bind to serum albumin and stay active for days instead of minutes — a single weekly or biweekly dose can elevate GH and IGF-1 in a sustained pattern.

A co-formulated GH-secretagogue blend: CJC-1295 without DAC (a Mod GRF 1-29 GHRH analog with a short, pulsatile action) paired with Ipamorelin (a selective ghrelin-pathway GH releaser).

Recombinant human growth hormone — the same 191-amino-acid sequence your body produces, expressed in E. coli. Standard 10 IU vial format.

A small five-amino-acid peptide that triggers GH release through the ghrelin pathway — without the cortisol, prolactin, or ACTH side effects of older secretagogues.

A peptide your mitochondria themselves encode and release — a signal that helps your cells handle metabolic stress. AMPK-activating; influences how your body uses glucose and fatty acids.

A stabilized growth-hormone-releasing hormone (GHRH) analog studied for its effects on visceral fat and GH/IGF-1 dynamics.

A Russian-developed peptide originally studied as an anxiety tool. Modulates GABA and serotonin pathways gently — researched for calm focus and stress resilience without sedation.

Russian-developed neuroactive peptide derived from a fragment of ACTH. Studied for focus, cognitive performance, and neuroprotection.

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied for its role in telomerase activity and circadian/endocrine regulation. A staple of longevity research.

A custom four-peptide blend supplied as a single vial. Composition: GHK-Cu, KPV, BPC-157, and TB-500.

The coenzyme your cells use to make energy. Levels naturally decline with age, stress, and metabolic load — which is why NAD+ shows up in so much longevity research.

0.9% benzyl-alcohol-preserved sterile water for reconstituting lyophilized peptides. The preservative lets a multi-dose vial be drawn from over multiple uses.